Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.05% | 87.30 | 1.3% | $1275.26m | |
| AMGN | Amgen Inc. | -0.25% | 198.89 | 1.2% | $667.61m | |
| GILD | Gilead Sciences, Inc. | -1.28% | 67.64 | 0.9% | $577.79m | |
| BIIB | Biogen Inc. | -1.63% | 332.03 | 1.3% | $485.41m | |
| LOXO | Loxo Oncology Inc | -0.18% | 233.26 | 12.7% | $449.60m | |
| ILMN | Illumina, Inc. | 0.05% | 305.63 | 3.5% | $350.96m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.28% | 186.15 | 1.9% | $318.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.12% | 404.54 | 2.6% | $308.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.03% | 111.70 | 2.0% | $229.47m | |
| TSRO | TESARO, Inc. | 0.03% | 74.88 | 14.4% | $201.67m | |
| A | Agilent Technologies, Inc. | -0.82% | 70.02 | 1.5% | $164.25m | |
| EXAS | Exact Sciences Corporation | -2.75% | 74.97 | 25.3% | $151.07m | |
| INCY | Incyte Corporation | -2.79% | 76.56 | 2.5% | $146.84m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.45% | 119.26 | 15.4% | $142.24m | |
| LGND | Ligand Pharmaceuticals Incorporated | -16.48% | 110.05 | 23.1% | $105.44m |
Company Profile
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The company focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer on June 15, 2015 and is headquartered in Lexington, MA.